Updates

Areas of Research Cancer Genetics and Genomics

The Cancer Genetics and Genomics Program at Texas Children’s Hospital is focused on providing clinical services and conducting research related to pediatric cancer.

Our goal is to develop novel strategies for understanding, diagnosing, treating, and preventing cancer. These research activities include, but are not limited to:

  • Understanding genetic susceptibility to cancer and fundamental mechanisms of genomic instability
  • Identifying biologically and clinically-relevant genetic alterations driving childhood tumors
  • Determining best practices for clinical implementation of genome-scale testing
  • Developing novel therapeutics and biomarkers that are based on an understanding of genetic alterations in childhood cancers

The cancer genetics and genomics research laboratories occupy over 5,500 square feet of state-of-the-art laboratory space. The recently renovated areas are well equipped for research in genetics, genomics, and cellular and molecular biology.

LEARN MORE ABOUT OUR CANCER GENETICS & GENOMICS RESEARCH

Mission

Patient Care. To provide state-of-the-art evaluation of and management for children and their families with hereditary predisposition to cancer

Research. To investigate genetic susceptibility to cancer and fundamental mechanisms of genomic instability, biologically and clinically-relevant genetic alterations driving childhood tumors, and the clinical implementation of genome-scale testing

Education. To train future clinicians and scientists at all educational stages in cancer genetics and genomics

Center for Precision Oncology. Aiming to discover the genetic make-up of each child’s tumor

LEARN MORE

Contact Us

Physicians may call our clinics at 1-800-226-2379. Families may contact us at 832-824-4685.

Explore Our Areas of Research in Cancer and Blood Disorders

Bone Marrow Failure Stem Cell Transplantation and Cellular Therapy Bone Tumors Brain Tumors Cancer Genetics and Genomics Cancer Survivorship Cell and Gene Therapy Developmental Therapeutics Epidemiology (Cancer and Hematology) Ewing Sarcoma Hemostasis and Thrombosis Histiocytosis Immune Hematology Immunotherapy Leukemia Liver Tumors Lymphoma Menorrhagia and Young Women's Bleeding Disorders Neuroblastoma Precision Oncology Rare Tumors Retinoblastoma Sickle Cell Disease and Thalassemia Soft Tissue Sarcoma Solid Tumors Thyroid Tumors
Bone Marrow Failure Bone Tumors Cancer Genetics and Genomics Cell and Gene Therapy Epidemiology (Cancer and Hematology) Hemostasis and Thrombosis Immune Hematology Leukemia Lymphoma Neuroblastoma Rare Tumors Sickle Cell Disease and Thalassemia Solid Tumors Stem Cell Transplantation and Cellular Therapy Brain Tumors Cancer Survivorship Developmental Therapeutics Ewing Sarcoma Histiocytosis Immunotherapy Liver Tumors Menorrhagia and Young Women's Bleeding Disorders Precision Oncology Retinoblastoma Soft Tissue Sarcoma Thyroid Tumors
Bone Marrow Failure Cancer Genetics and Genomics Epidemiology (Cancer and Hematology) Immune Hematology Lymphoma Rare Tumors Solid Tumors Stem Cell Transplantation and Cellular Therapy Cancer Survivorship Ewing Sarcoma Immunotherapy Menorrhagia and Young Women's Bleeding Disorders Retinoblastoma Thyroid Tumors Bone Tumors Cell and Gene Therapy Hemostasis and Thrombosis Leukemia Neuroblastoma Sickle Cell Disease and Thalassemia Brain Tumors Developmental Therapeutics Histiocytosis Liver Tumors Precision Oncology Soft Tissue Sarcoma

Ranked #6 in Cancer

Proud to be ranked one of the best children’s cancer centers in the country by U.S. News & World Report for seven consecutive years.

See Rankings

Related Departments